eprintid: 52939
rev_number: 1
eprint_status: archive
userid: 1
dir: disk0/00/05/29/39
datestamp: 2026-05-26 15:45:57
lastmod: 2026-05-26 15:45:57
status_changed: 2026-05-26 15:45:57
type: article
metadata_visibility: show
sword_depositor: 1
creators_name: oʻgʻli, Ergashev Asilbek Qudrat
creators_name: oʻgʻli, Abdunazarov Azimjon Alisher
creators_name: Yuldashevich, Chariev Muzaffar
title: CLINICAL PHARMACOLOGY OF ANTIVIRAL DRUGS
ispublished: pub
subjects: antiviral drugs, integrase inhibitors, mechanism of action, nucleoside and nucleotide reverse transcriptase inhibitors, protease inhibitors, viral infections.
keywords: antiviral drugs, integrase inhibitors, mechanism of action, nucleoside and nucleotide reverse transcriptase inhibitors, protease inhibitors, viral infections.
note: Imported from MJST Journal (OAI id oai:ojs.pkp.sfu.ca:article/731)
abstract: This article discusses the clinical pharmacology, mechanism of action, time of action, types and composition of antiviral drugs. The article introduces new antiviral drugs being developed in the pharmaceutical industry, their pharmacotherapeutic groups, international non-patented names, and the country of manufacture. Nowadays, the need for antiviral drugs is increasing. Because it is the time when seasonal viral diseases and allergies are on the rise and immunity decreases to a certain extent. Therefore, we will get acquainted with the new anti-viral drugs included in the State Register.
date: 2024-01-20
date_type: published
publisher: Center for Tech and Media Research
official_url: https://mjstjournal.com/index.php/mjst/article/view/731
id_number: oai:ojs.pkp.sfu.ca:article/731
full_text_status: none
publication: Multidisciplinary Journal of Science and Technology
citation:   oʻgʻli, Ergashev Asilbek Qudrat, oʻgʻli, Abdunazarov Azimjon Alisher, Yuldashevich, Chariev Muzaffar  (2024) CLINICAL PHARMACOLOGY OF ANTIVIRAL DRUGS.  Multidisciplinary Journal of Science and Technology.